Warning: The NCBI web site requires JavaScript to function. more...
Fetching bibliography...
Generate a file for use with external citation management software.
Correlation between cystometric volumes, ATP release, and pH in women with overactive bladder versus controls.
Cheng Y, Mansfield KJ, Allen W, Millard RJ, Burcher E, Moore KH.
Neurourol Urodyn. 2013 Sep;32(7):969-73. doi: 10.1002/nau.22344. Epub 2012 Nov 5.
Similar articles
Comparison of receptor binding characteristics of commonly used muscarinic antagonists in human bladder detrusor and mucosa.
Mansfield KJ, Chandran JJ, Vaux KJ, Millard RJ, Christopoulos A, Mitchelson FJ, Burcher E.
J Pharmacol Exp Ther. 2009 Mar;328(3):893-9. doi: 10.1124/jpet.108.145508. Epub 2008 Nov 24.
Long-term darifenacin treatment for overactive bladder in patients aged 65 years and older: analysis of results from a 2-year, open-label extension study.
Hill S, Elhilali M, Millard RJ, Dwyer PL, Lheritier K, Kawakami FT, Steel M.
Curr Med Res Opin. 2007 Nov;23(11):2697-704.
Molecular characterization of M2 and M3 muscarinic receptor expression in bladder from women with refractory idiopathic detrusor overactivity.
Mansfield KJ, Liu L, Moore KH, Vaux KJ, Millard RJ, Burcher E.
BJU Int. 2007 Jun;99(6):1433-8.
Age-related changes of P2X(1) receptor mRNA in the bladder detrusor from men with and without bladder outlet obstruction.
Chua WC, Liu L, Mansfield KJ, Vaux KJ, Moore KH, Millard RJ, Burcher E.
Exp Gerontol. 2007 Jul;42(7):686-92. Epub 2007 Feb 20.
The molecular basis of urgency: regional difference of vanilloid receptor expression in the human urinary bladder.
Liu L, Mansfield KJ, Kristiana I, Vaux KJ, Millard RJ, Burcher E.
Neurourol Urodyn. 2007;26(3):433-8; discussion 439; discussion 451-3.
Efficacy of solifenacin in patients with severe symptoms of overactive bladder: a pooled analysis.
Millard RJ, Halaska M.
Curr Med Res Opin. 2006 Jan;22(1):41-8.
Muscarinic receptor subtypes in human bladder detrusor and mucosa, studied by radioligand binding and quantitative competitive RT-PCR: changes in ageing.
Mansfield KJ, Liu L, Mitchelson FJ, Moore KH, Millard RJ, Burcher E.
Br J Pharmacol. 2005 Apr;144(8):1089-99.
Duloxetine vs placebo in the treatment of stress urinary incontinence: a four-continent randomized clinical trial.
Millard RJ, Moore K, Rencken R, Yalcin I, Bump RC; Duloxetine UI Study Group.
BJU Int. 2004 Feb;93(3):311-8.
Clinical efficacy of tolterodine with or without a simplified pelvic floor exercise regimen.
Millard RJ; Asia Pacific Tolterodine Study Group.
Neurourol Urodyn. 2004;23(1):48-53.
Enhancement of neurokinin A-induced smooth muscle contraction in human urinary bladder by mucosal removal and phosphoramidon: relationship to peptidase inhibition.
Warner FJ, Shang F, Millard RJ, Burcher E.
Eur J Pharmacol. 2002 Mar 8;438(3):171-7.
Autoradiographic localization of tachykinin and calcitonin gene-related peptide receptors in adult urinary bladder.
Burcher E, Zeng XP, Strigas J, Shang F, Millard RJ, Moore KH.
J Urol. 2000 Jan;163(1):331-7.
The aging bladder: morphology and urodynamics.
Elbadawi A, Diokno AC, Millard RJ.
World J Urol. 1998;16 Suppl 1:S10-34. Review. No abstract available.
Relationships between lower urinary tract symptoms and bladder outlet obstruction: results from the ICS-"BPH" study.
de la Rosette JJ, Witjes WP, Schäfer W, Abrams P, Donovan JL, Peters TJ, Millard RJ, Frimodt-Møller C, Kalomiris P.
Neurourol Urodyn. 1998;17(2):99-108.
Early clinical experience with continent urinary diversion.
Millard RJ, Wang Y.
Aust N Z J Surg. 1996 Dec;66(12):826-9.
Urinary urge incontinence: randomised crossover trials of penthienate versus placebo and propantheline.
Coombes GM, Millard RJ.
Med J Aust. 1996 Nov 4;165(9):473-6.
Urinary incontinence: the Cinderella subject.
Millard RJ, Moore KH.
Med J Aust. 1996 Aug 5;165(3):124-5. No abstract available.
Risks of self-injection therapy for impotence.
Millard RJ, Stricker PD, Lynch WJ, Dean TE, Murnaghan GF, Breslin FH.
Med J Aust. 1996 Jul 15;165(2):117-8. No abstract available.
A study of the efficacy and safety of transurethral needle ablation (TUNA) treatment for benign prostatic hyperplasia.
Millard RJ, Harewood LM, Tamaddon K.
Neurourol Urodyn. 1996;15(6):619-28; discussion 628-9.
The accuracy of portable ultrasound scanning in the measurement of residual urine volume.
J Urol. 1994 Dec;152(6 Pt 1):2083-5.
Controlled trial evaluation of a General Practitioner education package on incontinence: use of a mailed questionnaire.
Szonyi G, Millard RJ.
Br J Urol. 1994 Jun;73(6):615-20.
Bladder cancer in patients on low-dose methotrexate and corticosteroids.
Millard RJ, McCredie S.
Lancet. 1994 May 14;343(8907):1222-3. No abstract available.
The management of invasive transitional cell carcinoma of the bladder. Results of definitive and preoperative radiation therapy in 390 patients treated at the Prince of Wales Hospital, Sydney, Australia.
Mameghan H, Fisher RJ, Watt WH, Meagher MJ, Rosen IM, Mameghan J, Brook S, Tynan AP, Korbel EI, Millard RJ, et al.
Cancer. 1992 Jun 1;69(11):2771-8.
Management of incontinence: a urological approach.
Millard RJ.
Aust Fam Physician. 1989 Aug;18(8):958-63. Review.
The accuracy of a catheterized residual urine.
Stoller ML, Millard RJ.
J Urol. 1989 Jan;141(1):15-6.
Management of refractory detrusor instability by transvesical phenol injection.
Cameron-Strange A, Millard RJ.
Br J Urol. 1988 Oct;62(4):323-5.
Management of urinary retention.
Aust Fam Physician. 1986 Dec;15(12):1560-1, 1563. No abstract available.
Predictors of long term outcome following a bladder re-training programme.
Oldenburg B, Millard RJ.
J Psychosom Res. 1986;30(6):691-8.
Urodynamic evaluation of bladder neck obstruction in chronic prostatitis.
Murnaghan GF, Millard RJ.
Br J Urol. 1984 Dec;56(6):713-6.
The clinical significance of bladder speed.
Br J Urol. 1984 Apr;56(2):165-71.
The symptomatic, urodynamic and psychodynamic results of bladder re-education programs.
Millard RJ, Oldenburg BF.
J Urol. 1983 Oct;130(4):715-9.
Divergent perspectives in abortion counseling.
Gibb GD, Millard RJ.
Psychol Rep. 1982 Jun;50(3 Pt 1):819-22.
Preliminary findings of personality differences between nulliparas and repeated aborters along the dimensions of locus of control and impulsivity.
Psychol Rep. 1981 Oct;49(2):413-4. No abstract available.
Busulfan-induced hemorrhagic cystitis.
Urology. 1981 Aug;18(2):143-4.
Research on repeated abortion: state of the field: 1973-1979.
Psychol Rep. 1981 Apr;48(2):415-24. No abstract available.
Experimental evaluation of the urethral response to section of the spinal cord or cauda equina and to the electrostimulation of the bladder in non-human primates.
Murnaghan GF, Gowland SP, Rose MA, Millard RJ, Stening WA.
Paraplegia. 1980 Aug;18(4):246-57.
Controlled clinical trial comparing intra-incisional cephaloridine and Polybactrin Spray.
Gow NM, Millard RJ, Croft RJ, Dash CH.
Chemotherapy. 1980;26(1):64-71.
Experimental neurogenic disorders of the bladder after section of cauda equina.
Murnaghan GF, Gowland SP, Rose M, Millard RJ, Stening WA.
Br J Urol. 1979 Dec;51(6):518-23.
Busulphan haemorrhagic cystitis.
Br J Urol. 1978 May;50(3):210. No abstract available.
How much intravenous fluid does the patient get?
Lancet. 1977 Sep 24;2(8039):665-6. No abstract available.
Antimicrobial prophylaxis at laparotomy.
Menzies-Gow N, Millard RJ, Dash CH.
Lancet. 1977 Jul 23;2(8030):196. No abstract available.
Nitrofurantoin lung.
Ngan H, Millard RJ, Lant AF, Trapnell DH.
Br J Radiol. 1971 Jan;44(517):21-3. No abstract available.
Filters: Manage Filters